Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib

被引：0
|
作者：
Hua Cheng
She-Juan An
Song Dong
Yi-Fang Zhang
Xu-Chao Zhang
Zhi-Hong Chen
Yi-Long Jian-Su
机构：
[1] Guangdong Lung Cancer Institute; Medical Research Center of Guangdong General Hospital & Guangdong Academy of Medical Sciences,
[2] Thoracic oncology,undefined
[3] the fifth affiliated hospital of Sun Yat-Sen university,undefined
来源：
Journal of Hematology & Oncology | / 4卷
关键词：
Paclitaxel; Gefitinib; Erlotinib; H1650 Cell; Combination Index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Gefitinib in non-small cell lung cancer
    Tamura, K
    Fukuoka, M
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 985 - 993
  • [42] The past, present, and future management of brain metastases in EGFR-mutant non-small cell lung cancer
    Sperduto, Paul W.
    Lou, Emil
    NEURO-ONCOLOGY, 2021, 23 (06) : 867 - 868
  • [43] BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancer
    Fan, Fushun
    Zhou, Minhua
    Ye, Xiaolan
    Mo, Zhenxian
    Ma, Yaru
    Luo, Liying
    Liang, Xiaotong
    Liu, Haiqi
    Weng, Yunwo
    Lin, Mingsheng
    Liu, Xinjian
    Cai, Xiong
    Qian, Changgeng
    TRANSLATIONAL ONCOLOGY, 2021, 14 (02):
  • [44] Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer
    Pina, Pamela Soberanis
    Lara-Mejia, Luis
    Matias-Cruz, Venecia
    Barron, Feliciano
    Cardona, Andres F.
    Raez, Luis E.
    Rios-Garcia, Eduardo
    Arrieta, Oscar
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancer
    Lin, Chien-Yu
    Chou, Yun-Tse
    Su, Po-Lan
    Lin, Chien-Chung
    Chang, John Wen-Cheng
    Huang, Chen-Yang
    Fang, Yueh-Fu
    Chang, Ching-Fu
    Kuo, Chih-Hsi Scott
    Hsu, Ping-Chih
    Yang, Cheng-Ta
    Wu, Chiao-En
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (09): : 4208 - +
  • [46] Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
    Passiglia, Francesco
    Bironzo, Paolo
    Bertaglia, Valentina
    Listi, Angela
    Garbo, Edoardo
    Scagliotti, Giorgio Vittorio
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (05) : 935 - 949
  • [47] Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach
    Jassem, Jacek
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S387 - S390
  • [48] Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703
    Kudo, Kenichiro
    Hotta, Katsuyuki
    Ichihara, Eiki
    Yoshioka, Hiroshige
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Iwasaku, Masahiro
    Kato, Yuka
    Oze, Isao
    Takigawa, Nagio
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 251 - 256
  • [49] Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703
    Kenichiro Kudo
    Katsuyuki Hotta
    Eiki Ichihara
    Hiroshige Yoshioka
    Kei Kunimasa
    Kazuya Tsubouchi
    Masahiro Iwasaku
    Yuka Kato
    Isao Oze
    Nagio Takigawa
    Mitsune Tanimoto
    Katsuyuki Kiura
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 251 - 256
  • [50] Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines
    Galetti, Maricla
    Alfieri, Roberta R.
    Cavazzoni, Andrea
    La Monica, Silvia
    Bonelli, Mara
    Fumarola, Claudia
    Mozzoni, Paola
    De Palma, Giuseppe
    Andreoli, Roberta
    Mutti, Antonio
    Mor, Marco
    Tiseo, Marcello
    Ardizzoni, Andrea
    Petronini, Pier Giorgio
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (02) : 179 - 187
12345